Bone Sarcoma Trials
Trial Name
Subtype
Agents
Phase
Status
Sponsor
Ewing's sarcoma
Different chemotherapy regimens
II/III
Open, recruiting
University of Birmingham
Conventional chondrosarcoma
Ivosidenib vs. placebo
III
Open, recruiting
Servier Bio-Innovation LLC
Ewing Sarcoma / SDH-deficient GIST
INBRX-109
I
Open, recruiting
INHIBRX Inc.
Ewing's sarcoma, Chondrosarcomas, Osteosarcomas, Chondromas
Regorafenib vs. placebo
II
Open, recruiting (France only)
UNICANCER
Ewing Sarcoma in children/young adults
Lurbinectedin
I/II
Open, recruiting
Jazz Pharmaceuticals
Solid tumors incl. soft tissue and bone sarcomas
TNG462
I/II
Open, recruiting
Tango Therapeutics
Ewing's Sarcoma
Abemaciclib (LY2835219) + Irinotecan + Temozolomide
II
Open, recruiting
Eli Lilly and Company
Ewing Sarcoma / Pediatric Patients
Palbociclib in combination with chemotherapy
II
Closed for recruitment, but active
Pfizer
Solid tumors incl. soft tissue and bone sarcomas
TNG908
I/II
Closed for recruitment
Tango Therapeutics
National trial lists
Some of our SPAGN member groups run clinical trial registries to inform about national and international trials in their respective countries.
Browse here to find out more:
- ONTEX: The Osteosarcoma Now Trial Explorer
- Sarcoma UK
- The Bone Cancer Research Trust, UK
- The German Sarcoma Foundation (Deutsche Sarkom-Stiftung), Germany
- The Sarcoma Foundation of America, USA
- The Chordoma Foundation, USA
- Fondazione Paola Gonzato Rete Sarcoma ETS
- Info Sarcomes, France - for Soft Tissue Sarcomas, Bone Sarcomas and GIST
Consortia dealing with bone sarcomas
These consortia develop and maintain a strategy to enhance collaboration among clinicians, researchers, and patient advocates across Europe and/or globally. Their goal is to strengthen and align efforts to address the current gaps in knowledge and treatment for specific subtypes of bone sarcomas.